Metaplastic carcinomas of the breast. II. Spindle cell carcinoma

The clinical and pathologic features of 100 examples of spindle cell carcinoma (SpCC) of the breast are reported. Eighty-three neoplasms contained overt carcinoma; 72 had infiltrating ductal or intraductal carcinoma and in 11 the carcinomatous component was purely squamous. Seventeen neoplasms lacke...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human pathology 1989-08, Vol.20 (8), p.732-740
Hauptverfasser: Wargotz, Eric S., Does, Phillip H., Norris, Henry J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 740
container_issue 8
container_start_page 732
container_title Human pathology
container_volume 20
creator Wargotz, Eric S.
Does, Phillip H.
Norris, Henry J.
description The clinical and pathologic features of 100 examples of spindle cell carcinoma (SpCC) of the breast are reported. Eighty-three neoplasms contained overt carcinoma; 72 had infiltrating ductal or intraductal carcinoma and in 11 the carcinomatous component was purely squamous. Seventeen neoplasms lacked overt carcinoma, but were identified as SpCC by immunoreactivity for keratin and the typical bland spindle cell proliferation forming a variable complex of fibrocollagenous stroma with feathered, myxoid, angioid, and storiform patterns. Areas of epithelium merging imperceptibly with the spindle cell component were commonly observed. Sixty neoplasms were studied by immunohistochemistry for the presence of keratin, epithelial membrane antigen (EMA), vimentin, S-100, and actin. The spindle cell component in 98% of SpCC was immunoreactive for keratin. Most were also immunoreactive for vimentin and actin, and in approximately one half, S-100 immunoreactivity was noted. These findings, in conjunction with histopathologic features, and ultrastructural observations from three cases, support myoepithelium as an integral component of SpCC. The cumulative 5-year survival rate for SpCC was 64%, better than survival rates usually reported for metaplastic carcinomas. Of 47 patients with axillary dissection, only 6% had metastases to axillary lymph nodes. Development of metastasis was an ominous sign as 29 of the 30 patients who developed metastases died from tumor. Local recurrence was not as ominous as only 29% who had only local recurrence subsequently died from tumor. The difference in size between tumors that recurred (mean, 5.0 cm) and those that did not (mean 3.7 cm), and the presence or absence of complete microscopic circumscription, were both significant prognostic factors.
doi_str_mv 10.1016/0046-8177(89)90065-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79077459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0046817789900658</els_id><sourcerecordid>79077459</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-e84cd26d659049b96985368d4b96bf4f3f0b39ffd8a39d49f9e357122e3662283</originalsourceid><addsrcrecordid>eNp9kMtKBDEQRYMoOo7-gUJvFF30mFenk40o4mNAcaGuQzqpYKQfY9Ij-Pd2O4Ozc1UF99SlOAgdETwjmIgLjLnIJSnLM6nOFcaiyOUWmpCC0VwyRbfR5A_ZQ_spfWBMSMGLXbRLeckw5RN09QS9WdQm9cFm1kQb2q4xKet81r9DVkUYolk2n8-yl0VoXQ2ZhbreoAdox5s6weF6TtHb3e3rzUP--Hw_v7l-zC0Tss9BcuuocKJQmKtKCSWLIXB8WCvPPfO4Ysp7Jw1TjiuvgBUloRSYEJRKNkWnq95F7D6XkHrdhDS-YlrolkmXCpclL9QA8hVoY5dSBK8XMTQmfmuC9ShOj1b0aEVLpX_F6bH_eN2_rBpwf0drU0N-ss5Nsqb20bQ2pE23YqUihAzc5YqDQcZXgKiTDdBacCGC7bXrwv-P_ACawYeV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79077459</pqid></control><display><type>article</type><title>Metaplastic carcinomas of the breast. II. Spindle cell carcinoma</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Wargotz, Eric S. ; Does, Phillip H. ; Norris, Henry J.</creator><creatorcontrib>Wargotz, Eric S. ; Does, Phillip H. ; Norris, Henry J.</creatorcontrib><description>The clinical and pathologic features of 100 examples of spindle cell carcinoma (SpCC) of the breast are reported. Eighty-three neoplasms contained overt carcinoma; 72 had infiltrating ductal or intraductal carcinoma and in 11 the carcinomatous component was purely squamous. Seventeen neoplasms lacked overt carcinoma, but were identified as SpCC by immunoreactivity for keratin and the typical bland spindle cell proliferation forming a variable complex of fibrocollagenous stroma with feathered, myxoid, angioid, and storiform patterns. Areas of epithelium merging imperceptibly with the spindle cell component were commonly observed. Sixty neoplasms were studied by immunohistochemistry for the presence of keratin, epithelial membrane antigen (EMA), vimentin, S-100, and actin. The spindle cell component in 98% of SpCC was immunoreactive for keratin. Most were also immunoreactive for vimentin and actin, and in approximately one half, S-100 immunoreactivity was noted. These findings, in conjunction with histopathologic features, and ultrastructural observations from three cases, support myoepithelium as an integral component of SpCC. The cumulative 5-year survival rate for SpCC was 64%, better than survival rates usually reported for metaplastic carcinomas. Of 47 patients with axillary dissection, only 6% had metastases to axillary lymph nodes. Development of metastasis was an ominous sign as 29 of the 30 patients who developed metastases died from tumor. Local recurrence was not as ominous as only 29% who had only local recurrence subsequently died from tumor. The difference in size between tumors that recurred (mean, 5.0 cm) and those that did not (mean 3.7 cm), and the presence or absence of complete microscopic circumscription, were both significant prognostic factors.</description><identifier>ISSN: 0046-8177</identifier><identifier>EISSN: 1532-8392</identifier><identifier>DOI: 10.1016/0046-8177(89)90065-8</identifier><identifier>PMID: 2473024</identifier><identifier>CODEN: HPCQA4</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; breast carcinoma with pseudosarcomatous metaplasia/stroma ; Breast Neoplasms - analysis ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Breast Neoplasms - ultrastructure ; Carcinoma - analysis ; Carcinoma - mortality ; Carcinoma - pathology ; Carcinoma - ultrastructure ; carcinosarcoma ; electron microscopy ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Immunohistochemistry ; Keratins - analysis ; Mammary gland diseases ; Medical sciences ; metaplastic carcinoma ; Middle Aged ; myoepithelium ; Neoplasm Recurrence, Local ; spindle cell carcinoma ; squamous carcinoma ; Tumors ; Vimentin - analysis</subject><ispartof>Human pathology, 1989-08, Vol.20 (8), p.732-740</ispartof><rights>1989</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-e84cd26d659049b96985368d4b96bf4f3f0b39ffd8a39d49f9e357122e3662283</citedby><cites>FETCH-LOGICAL-c368t-e84cd26d659049b96985368d4b96bf4f3f0b39ffd8a39d49f9e357122e3662283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0046-8177(89)90065-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19379111$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2473024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wargotz, Eric S.</creatorcontrib><creatorcontrib>Does, Phillip H.</creatorcontrib><creatorcontrib>Norris, Henry J.</creatorcontrib><title>Metaplastic carcinomas of the breast. II. Spindle cell carcinoma</title><title>Human pathology</title><addtitle>Hum Pathol</addtitle><description>The clinical and pathologic features of 100 examples of spindle cell carcinoma (SpCC) of the breast are reported. Eighty-three neoplasms contained overt carcinoma; 72 had infiltrating ductal or intraductal carcinoma and in 11 the carcinomatous component was purely squamous. Seventeen neoplasms lacked overt carcinoma, but were identified as SpCC by immunoreactivity for keratin and the typical bland spindle cell proliferation forming a variable complex of fibrocollagenous stroma with feathered, myxoid, angioid, and storiform patterns. Areas of epithelium merging imperceptibly with the spindle cell component were commonly observed. Sixty neoplasms were studied by immunohistochemistry for the presence of keratin, epithelial membrane antigen (EMA), vimentin, S-100, and actin. The spindle cell component in 98% of SpCC was immunoreactive for keratin. Most were also immunoreactive for vimentin and actin, and in approximately one half, S-100 immunoreactivity was noted. These findings, in conjunction with histopathologic features, and ultrastructural observations from three cases, support myoepithelium as an integral component of SpCC. The cumulative 5-year survival rate for SpCC was 64%, better than survival rates usually reported for metaplastic carcinomas. Of 47 patients with axillary dissection, only 6% had metastases to axillary lymph nodes. Development of metastasis was an ominous sign as 29 of the 30 patients who developed metastases died from tumor. Local recurrence was not as ominous as only 29% who had only local recurrence subsequently died from tumor. The difference in size between tumors that recurred (mean, 5.0 cm) and those that did not (mean 3.7 cm), and the presence or absence of complete microscopic circumscription, were both significant prognostic factors.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>breast carcinoma with pseudosarcomatous metaplasia/stroma</subject><subject>Breast Neoplasms - analysis</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - ultrastructure</subject><subject>Carcinoma - analysis</subject><subject>Carcinoma - mortality</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - ultrastructure</subject><subject>carcinosarcoma</subject><subject>electron microscopy</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Keratins - analysis</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>metaplastic carcinoma</subject><subject>Middle Aged</subject><subject>myoepithelium</subject><subject>Neoplasm Recurrence, Local</subject><subject>spindle cell carcinoma</subject><subject>squamous carcinoma</subject><subject>Tumors</subject><subject>Vimentin - analysis</subject><issn>0046-8177</issn><issn>1532-8392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKBDEQRYMoOo7-gUJvFF30mFenk40o4mNAcaGuQzqpYKQfY9Ij-Pd2O4Ozc1UF99SlOAgdETwjmIgLjLnIJSnLM6nOFcaiyOUWmpCC0VwyRbfR5A_ZQ_spfWBMSMGLXbRLeckw5RN09QS9WdQm9cFm1kQb2q4xKet81r9DVkUYolk2n8-yl0VoXQ2ZhbreoAdox5s6weF6TtHb3e3rzUP--Hw_v7l-zC0Tss9BcuuocKJQmKtKCSWLIXB8WCvPPfO4Ysp7Jw1TjiuvgBUloRSYEJRKNkWnq95F7D6XkHrdhDS-YlrolkmXCpclL9QA8hVoY5dSBK8XMTQmfmuC9ShOj1b0aEVLpX_F6bH_eN2_rBpwf0drU0N-ss5Nsqb20bQ2pE23YqUihAzc5YqDQcZXgKiTDdBacCGC7bXrwv-P_ACawYeV</recordid><startdate>198908</startdate><enddate>198908</enddate><creator>Wargotz, Eric S.</creator><creator>Does, Phillip H.</creator><creator>Norris, Henry J.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198908</creationdate><title>Metaplastic carcinomas of the breast. II. Spindle cell carcinoma</title><author>Wargotz, Eric S. ; Does, Phillip H. ; Norris, Henry J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-e84cd26d659049b96985368d4b96bf4f3f0b39ffd8a39d49f9e357122e3662283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>breast carcinoma with pseudosarcomatous metaplasia/stroma</topic><topic>Breast Neoplasms - analysis</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - ultrastructure</topic><topic>Carcinoma - analysis</topic><topic>Carcinoma - mortality</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - ultrastructure</topic><topic>carcinosarcoma</topic><topic>electron microscopy</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Keratins - analysis</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>metaplastic carcinoma</topic><topic>Middle Aged</topic><topic>myoepithelium</topic><topic>Neoplasm Recurrence, Local</topic><topic>spindle cell carcinoma</topic><topic>squamous carcinoma</topic><topic>Tumors</topic><topic>Vimentin - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wargotz, Eric S.</creatorcontrib><creatorcontrib>Does, Phillip H.</creatorcontrib><creatorcontrib>Norris, Henry J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wargotz, Eric S.</au><au>Does, Phillip H.</au><au>Norris, Henry J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metaplastic carcinomas of the breast. II. Spindle cell carcinoma</atitle><jtitle>Human pathology</jtitle><addtitle>Hum Pathol</addtitle><date>1989-08</date><risdate>1989</risdate><volume>20</volume><issue>8</issue><spage>732</spage><epage>740</epage><pages>732-740</pages><issn>0046-8177</issn><eissn>1532-8392</eissn><coden>HPCQA4</coden><abstract>The clinical and pathologic features of 100 examples of spindle cell carcinoma (SpCC) of the breast are reported. Eighty-three neoplasms contained overt carcinoma; 72 had infiltrating ductal or intraductal carcinoma and in 11 the carcinomatous component was purely squamous. Seventeen neoplasms lacked overt carcinoma, but were identified as SpCC by immunoreactivity for keratin and the typical bland spindle cell proliferation forming a variable complex of fibrocollagenous stroma with feathered, myxoid, angioid, and storiform patterns. Areas of epithelium merging imperceptibly with the spindle cell component were commonly observed. Sixty neoplasms were studied by immunohistochemistry for the presence of keratin, epithelial membrane antigen (EMA), vimentin, S-100, and actin. The spindle cell component in 98% of SpCC was immunoreactive for keratin. Most were also immunoreactive for vimentin and actin, and in approximately one half, S-100 immunoreactivity was noted. These findings, in conjunction with histopathologic features, and ultrastructural observations from three cases, support myoepithelium as an integral component of SpCC. The cumulative 5-year survival rate for SpCC was 64%, better than survival rates usually reported for metaplastic carcinomas. Of 47 patients with axillary dissection, only 6% had metastases to axillary lymph nodes. Development of metastasis was an ominous sign as 29 of the 30 patients who developed metastases died from tumor. Local recurrence was not as ominous as only 29% who had only local recurrence subsequently died from tumor. The difference in size between tumors that recurred (mean, 5.0 cm) and those that did not (mean 3.7 cm), and the presence or absence of complete microscopic circumscription, were both significant prognostic factors.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>2473024</pmid><doi>10.1016/0046-8177(89)90065-8</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0046-8177
ispartof Human pathology, 1989-08, Vol.20 (8), p.732-740
issn 0046-8177
1532-8392
language eng
recordid cdi_proquest_miscellaneous_79077459
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
breast carcinoma with pseudosarcomatous metaplasia/stroma
Breast Neoplasms - analysis
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Breast Neoplasms - ultrastructure
Carcinoma - analysis
Carcinoma - mortality
Carcinoma - pathology
Carcinoma - ultrastructure
carcinosarcoma
electron microscopy
Female
Gynecology. Andrology. Obstetrics
Humans
Immunohistochemistry
Keratins - analysis
Mammary gland diseases
Medical sciences
metaplastic carcinoma
Middle Aged
myoepithelium
Neoplasm Recurrence, Local
spindle cell carcinoma
squamous carcinoma
Tumors
Vimentin - analysis
title Metaplastic carcinomas of the breast. II. Spindle cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T11%3A14%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metaplastic%20carcinomas%20of%20the%20breast.%20II.%20Spindle%20cell%20carcinoma&rft.jtitle=Human%20pathology&rft.au=Wargotz,%20Eric%20S.&rft.date=1989-08&rft.volume=20&rft.issue=8&rft.spage=732&rft.epage=740&rft.pages=732-740&rft.issn=0046-8177&rft.eissn=1532-8392&rft.coden=HPCQA4&rft_id=info:doi/10.1016/0046-8177(89)90065-8&rft_dat=%3Cproquest_cross%3E79077459%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79077459&rft_id=info:pmid/2473024&rft_els_id=0046817789900658&rfr_iscdi=true